NAS:AMED (USA) Also trade in: Germany Mexico

Amedisys Inc

$ 120.71 1.18 (0.99%)
Volume: 203,365 Avg Vol (1m): 422,586
Market Cap $: 3.87 Bil Enterprise Value $: 4.17 Bil
P/E (TTM): 32.35 P/B: 7.64
Earnings Power Value 36.11
Net Current Asset Value -11.93
Tangible Book -5.84
Projected FCF 34.13
Median P/S Value 41.26
Graham Number 16.24
Peter Lynch Value 82.25
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.03
Cash-To-Debt ranked higher than
64.60% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
AMED: 0.03
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0, Med: 0.29, Max: 23.47
Current: 0.03
0
23.47
Equity-to-Asset 0.44
Equity-to-Asset ranked higher than
71.00% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
AMED: 0.44
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -0.31, Med: 0.56, Max: 0.79
Current: 0.44
-0.31
0.79
Debt-to-Equity 0.60
Debt-to-Equity ranked higher than
86.63% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
AMED: 0.6
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: -8.05, Med: 0.27, Max: 15.49
Current: 0.6
-8.05
15.49
Debt-to-EBITDA 1.59
Debt-to-EBITDA ranked higher than
82.09% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
AMED: 1.59
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -1.63, Med: 0.78, Max: 3.17
Current: 1.59
-1.63
3.17
Interest Coverage 18.13
Interest Coverage ranked higher than
65.20% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
AMED: 18.13
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1.02, Med: 12.28, Max: 22.96
Current: 18.13
1.02
22.96
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.53
DISTRESS
GREY
SAFE
Beneish M-Score -2.68
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 22.06%
WACC 10.12%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 9.45
Operating Margin ranked lower than
59.56% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
AMED: 9.45
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 0.36, Med: 6.25, Max: 15.25
Current: 9.45
0.36
15.25
Net Margin % 7.14
Net Margin ranked lower than
62.13% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
AMED: 7.14
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -26.96, Med: 1.53, Max: 8.98
Current: 7.14
-26.96
8.98
ROE % 25.70
ROE ranked lower than
58.82% of 255 companies
in the Medical Care industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
AMED: 25.7
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -54.77, Med: 4.77, Max: 25.7
Current: 25.7
-54.77
25.7
ROA % 14.62
ROA ranked higher than
53.48% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
AMED: 14.62
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -35.44, Med: 2.88, Max: 15.59
Current: 14.62
-35.44
15.59
ROC (Joel Greenblatt) % 460.07
ROC (Joel Greenblatt) ranked higher than
93.38% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
AMED: 460.07
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -326.21, Med: 93.58, Max: 486.85
Current: 460.07
-326.21
486.85
3-Year Total Revenue Growth Rate 9.10
3-Year Revenue Growth Rate ranked higher than
52.61% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
AMED: 8.4
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -26.1, Med: 6.7, Max: 47.3
Current: 8.4
-26.1
47.3
3-Year Total EBITDA Growth Rate 80.60
3-Year EBITDA Growth Rate ranked higher than
79.35% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
AMED: 79.5
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 19.6, Max: 190.3
Current: 79.5
0
190.3

» AMED's 30-Y Financials

Financials (Next Earnings Date: 2019-08-01)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:AMED

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621610    SIC : 8082
Compare NAS:LHCG BKK:BH-Q LSE:MDC ASX:HSO NAS:ACHC NAS:LPNT XSGO:BANMEDICA JSE:LHC NSE:APOLLOHOSP NYSE:AMN NYSE:THC NYSE:MD SAU:4002 NYSE:SEM XTER:RHK ISX:MIKA NYSE:CHE JSE:NTC TSE:7716 NYSE:EVHC
Traded in other countries ADY.Germany
Address 3854 American Way, Suite A, Baton Rouge, LA, USA, 70816
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue.

Ratios

Current vs industry vs history
PE Ratio (TTM) 32.35
PE Ratio ranked lower than
85.35% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 27.31, Min: 1.39
AMED: 32.35
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 4.65, Med: 29.96, Max: 79.39
Current: 32.35
4.65
79.39
Forward PE Ratio 30.21
Forward P/E ranked higher than
52.54% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
AMED: 30.21
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 32.35
PE without NRI ranked lower than
85.86% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 9999, Min: 1.39
AMED: 32.35
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 4.65, Med: 29.96, Max: 77.36
Current: 32.35
4.65
77.36
Price-to-Owner-Earnings 24.57
Price-to-Owner-Earnings ranked lower than
81.65% of 109 companies
in the Medical Care industry.
Industry Max: 8000, Med: 26.64, Min: 1.5
AMED: 24.57
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 4.12, Med: 25.45, Max: 258.7
Current: 24.57
4.12
258.7
PB Ratio 7.64
PB Ratio ranked lower than
69.57% of 253 companies
in the Medical Care industry.
Industry Max: 48, Med: 2.64, Min: 0.05
AMED: 7.64
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.5, Med: 2.09, Max: 9.78
Current: 7.64
0.5
9.78
PS Ratio 2.33
PS Ratio ranked higher than
59.54% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
AMED: 2.33
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.19, Med: 0.79, Max: 2.84
Current: 2.33
0.19
2.84
Price-to-Free-Cash-Flow 20.31
Price-to-Free-Cash-Flow ranked higher than
54.07% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
AMED: 20.31
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 2.96, Med: 11.34, Max: 45.03
Current: 20.31
2.96
45.03
Price-to-Operating-Cash-Flow 19.66
Price-to-Operating-Cash-Flow ranked lower than
68.28% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
AMED: 19.66
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.02, Med: 6.58, Max: 32.23
Current: 19.66
2.02
32.23
EV-to-EBIT 23.99
EV-to-EBIT ranked lower than
57.01% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
AMED: 23.99
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -178.9, Med: 7.4, Max: 2214.4
Current: 23.99
-178.9
2214.4
EV-to-EBITDA 21.41
EV-to-EBITDA ranked lower than
65.35% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
AMED: 21.41
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -7.5, Med: 7.1, Max: 65.5
Current: 21.41
-7.5
65.5
EV-to-Revenue 2.43
EV-to-Revenue ranked higher than
69.37% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
AMED: 2.43
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.3, Med: 0.9, Max: 2.8
Current: 2.43
0.3
2.8
Current Ratio 0.91
Current Ratio ranked higher than
53.46% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
AMED: 0.91
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.33, Med: 1.05, Max: 2.88
Current: 0.91
0.33
2.88
Quick Ratio 0.91
Quick Ratio ranked higher than
57.69% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
AMED: 0.91
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.31, Med: 1.02, Max: 2.85
Current: 0.91
0.31
2.85
Days Sales Outstanding 49.87
Days Sales Outstanding ranked lower than
61.23% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
AMED: 49.87
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 30.1, Med: 37.17, Max: 49.87
Current: 49.87
30.1
49.87
Days Payable 11.62
Days Payable ranked lower than
85.23% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
AMED: 11.62
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 8.33, Med: 10.62, Max: 13.28
Current: 11.62
8.33
13.28

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 3.54
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
63.37% of 101 companies
in the Medical Care industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
AMED: 3.54
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.16, Med: 1.53, Max: 86
Current: 3.54
0.16
86
Price-to-Median-PS-Value 2.93
Price-to-Median-PS-Value ranked lower than
86.06% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
AMED: 2.93
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.11, Med: 0.72, Max: 3.3
Current: 2.93
0.11
3.3
Price-to-Peter-Lynch-Fair-Value 1.47
Price-to-Peter-Lynch-Fair-Value ranked lower than
100.00% of 55 companies
in the Medical Care industry.
Industry Max: 23.11, Med: 2.08, Min: 0.48
AMED: 1.47
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.21, Med: 0.72, Max: 3.24
Current: 1.47
0.21
3.24
Price-to-Graham-Number 7.43
Price-to-Graham-Number ranked lower than
94.40% of 125 companies
in the Medical Care industry.
Industry Max: 49.08, Med: 2.41, Min: 0.42
AMED: 7.43
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 0.98, Med: 2.9, Max: 11.26
Current: 7.43
0.98
11.26
Earnings Yield (Joel Greenblatt) % 4.19
Earnings Yield (Greenblatt) ranked higher than
55.31% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
AMED: 4.19
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -124.5, Med: 4.1, Max: 32.8
Current: 4.19
-124.5
32.8
Forward Rate of Return (Yacktman) % 23.54
Forward Rate of Return ranked higher than
95.49% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
AMED: 23.54
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 7, Med: 28, Max: 47.2
Current: 23.54
7
47.2

More Statistics

Revenue (TTM) (Mil) $ 1,730.66
EPS (TTM) $ 3.73
Beta 1.34
Volatility % 51.05
52-Week Range $ 82.71 - 140.91
Shares Outstanding (Mil) 32.04

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y